Drugs / Dual therapy with 3TC in combination with DTG or ritonavir-boosted Darunavir (rDVR)
Dual therapy with 3TC in combination with DTG or ritonavir-boosted Darunavir (rDVR)
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06338826 | Feb 2025 → Sep 2027 expected | HIV infectious disease | ANRS, Emerging Infectious Diseases | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dual therapy with 3TC in combination with DTG or ritonavir-boosted Darunavir (rDVR) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06338826 ↗ |